Exchange: NASDAQ·Updated 02:46 PM EDT
EYPT logo

EYPT EyePoint Pharmaceuticals Inc

$4.58
$0.21
(4.38%)
Today
Reported EarningsAug 6
Mkt Cap$412.96M
Vol1.18M

About EYPT

EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
44

Bearish Sentiment

How do you feel about EYPT?

Advertisement|Remove ads.